Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mélanie Try

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Bulletin Du Cancer|May 22, 2021
[New European approvals: Carfilzomib with daratumumab and dexamethasone in refractory or relapsed multiple myeloma after a first line of treatment]Mélanie Try, Lionel Karlin
Bulletin Du Cancer|February 9, 2023
[Renal failure in multiple myeloma: Specific management issues]Mélanie Try, Stéphanie Harel
La Revue Du Praticien|June 23, 2021
[Targeted therapies and high blood pressure]Mélanie Try, Ariel Cohen, Stéphane Ederhy
Journal of Opioid Management|October 13, 2022
Discussion on methadone initiation protocols: A case reportMatthieu Delaye, Sophie Laurent, Mélanie Try, et al.
Bulletin Du Cancer|May 19, 2023
[Electrolyte disorders in oncological patients]Arnaud Saillant, Mélanie Try, Ariane Laparra, et al.
Cancer Medicine|September 26, 2022
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancerMatthieu Delaye, Adrien Rousseau, Mélanie Try, et al.
Archiv Der Pharmazie|May 5, 2024
Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in long-term rat modelNahid Tabibzadeh, Mathieu Klein, Mélanie Try, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 15, 2022
Onco-nephrology: Physicians' Expectations About a New SubspecialtyMatthieu Delaye, Mélanie Try, Adrien Rousseau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2024
Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measuresPauline Corbaux, Matthieu Bainaud, Adrien Rousseau, et al.
Kidney International Reports|April 14, 2025
Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding RegimenNathalie Chavarot, Lara Cabezas, Hannah Kaminski, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Bulletin Du Cancer|May 22, 2021
[New European approvals: Carfilzomib with daratumumab and dexamethasone in refractory or relapsed multiple myeloma after a first line of treatment]Mélanie Try, Lionel Karlin
Bulletin Du Cancer|February 9, 2023
[Renal failure in multiple myeloma: Specific management issues]Mélanie Try, Stéphanie Harel
La Revue Du Praticien|June 23, 2021
[Targeted therapies and high blood pressure]Mélanie Try, Ariel Cohen, Stéphane Ederhy
Journal of Opioid Management|October 13, 2022
Discussion on methadone initiation protocols: A case reportMatthieu Delaye, Sophie Laurent, Mélanie Try, et al.
Bulletin Du Cancer|May 19, 2023
[Electrolyte disorders in oncological patients]Arnaud Saillant, Mélanie Try, Ariane Laparra, et al.
Cancer Medicine|September 26, 2022
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancerMatthieu Delaye, Adrien Rousseau, Mélanie Try, et al.
Archiv Der Pharmazie|May 5, 2024
Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in long-term rat modelNahid Tabibzadeh, Mathieu Klein, Mélanie Try, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|July 15, 2022
Onco-nephrology: Physicians' Expectations About a New SubspecialtyMatthieu Delaye, Mélanie Try, Adrien Rousseau, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 1, 2024
Patients' knowledge about renal secondary effects of anti-tumoral drugs and renal protection measuresPauline Corbaux, Matthieu Bainaud, Adrien Rousseau, et al.
Kidney International Reports|April 14, 2025
Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding RegimenNathalie Chavarot, Lara Cabezas, Hannah Kaminski, et al.
Pageof 2